Company: Dr. Reddy's Laboratories Ltd. Category: IPO Notes


NULL
May 17, 2019, 3:50 p.m.
Publisher: moneycontrol.com

NULL
May 17, 2019, 3:50 p.m.
Publisher: moneycontrol.com

Shares of the drugmaker have gained 38 percent in the past 12 months, beating peers.
May 10, 2019, 10:31 a.m.

NULL
Feb. 1, 2019, 6:38 p.m.
Publisher: moneycontrol.com


Revenues from the quarter under review was up by one percent to Rs 3,850 crore, accordig to a press release by the city-based pharma major. It was Rs 3,806 crore in the same quarter last fiscal.
Feb. 1, 2019, 3:53 p.m.
Publisher: moneycontrol.com

U.S. government shutdown may hit Dr. Reddy’s plans to enter its largest market for generics of Suboxone.
Jan. 30, 2019, 10:25 a.m.

NULL
Oct. 26, 2018, 3:37 p.m.
Publisher: moneycontrol.com

Net Sales are expected to increase by 10.8 percent Y-o-Y (up 5.6 percent Q-o-Q) to Rs. 3,930 crore, according to HDFC Securities.
Oct. 17, 2018, 5:40 p.m.
Publisher: moneycontrol.com

Dr Reddys Laboratories has reported a consolidated total income from operations of Rs 3,736.50 crore and a net profit of Rs 476.10 crore for the quarter ended Jun-2018
Aug. 7, 2018, 12:36 p.m.
Publisher: moneycontrol.com

Dr Reddys Laboratories has reported a consolidated total income from operations of Rs 3,736.50 crore and a net profit of Rs 476.10 crore for the quarter ended Jun#39;18
July 27, 2018, 11:53 a.m.
Publisher: moneycontrol.com

-->